首页> 外文期刊>Biochemical and Biophysical Research Communications >MicroRNA-134 actives lipoprotein lipase-mediated lipid accumulation and inflammatory response by targeting angiopoietin-like 4 in THP-1 macrophages
【24h】

MicroRNA-134 actives lipoprotein lipase-mediated lipid accumulation and inflammatory response by targeting angiopoietin-like 4 in THP-1 macrophages

机译:通过靶向THP-1巨噬细胞中的血管生成素样4,MicroRNA-134激活脂蛋白脂肪酶介导的脂质蓄积和炎症反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Angiopoietin-like 4 (Angptl4), a secreted protein, is an important regulator to irreversibly inhibit lipoprotein lipase (LPL) activity. Macrophage LPL contributes to foam cell formation via a so-called"molecular bridge" between lipoproteins and receptors on cell surface. It has been reported that macrophage ANGPTL4 suppresses LPL activity, foam cell formation and inflammatory gene expression to reduce atherosclerosis development. Recently, some studies demonstrated that microRNA-134 is upregulated in atherosclerotic macrophages. Here we demonstrate that miR-134 directly binds to 3'UTR of ANGPTL4 mRNA to suppression the expression of ANGPTL4. To investigate the potential roles of macrophage miR-134, THP-1 macrophages were transfected with miR-134 mimics or inhibitors. Our results showed that LPL activity and protein were dramatically increased. We also found that miR-134 activated LPL-mediated lipid accumulation. Collectively, our findings indicate that miR-134 may regulate lipid accumulation and proinfiammatory cytokine secretion in macrophages by targeting the ANGPTL4 gene. Our results have also suggested a promising and potential therapeutic target for atherosclerosis. (C) 2016 Elsevier Inc. All rights reserved.
机译:血管生成素样4(Angptl4)是一种分泌蛋白,是不可逆地抑制脂蛋白脂酶(LPL)活性的重要调节剂。巨噬细胞LPL通过脂蛋白和细胞表面受体之间的所谓“分子桥”促进泡沫细胞的形成。据报道,巨噬细胞ANGPTL4抑制LPL活性,泡沫细胞形成和炎性基因表达以减少动脉粥样硬化的发展。最近,一些研究表明,microRNA-134在动脉粥样硬化巨噬细胞中被上调。在这里,我们证明了miR-134直接与ANGPTL4 mRNA的3'UTR结合以抑制ANGPTL4的表达。为了研究巨噬细胞miR-134的潜在作用,将THP-1巨噬细胞用miR-134模拟物或抑制剂转染。我们的结果表明,LPL活性和蛋白质显着增加。我们还发现miR-134激活LPL介导的脂质蓄积。总体而言,我们的研究结果表明,miR-134可能通过靶向ANGPTL4基因来调节巨噬细胞中的脂质蓄积和炎症前细胞因子的分泌。我们的结果也表明了动脉粥样硬化的有希望和潜在的治疗目标。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号